IL310009A - Cannabidiol esters for the treatment of Prader-Willi syndrome - Google Patents

Cannabidiol esters for the treatment of Prader-Willi syndrome

Info

Publication number
IL310009A
IL310009A IL310009A IL31000924A IL310009A IL 310009 A IL310009 A IL 310009A IL 310009 A IL310009 A IL 310009A IL 31000924 A IL31000924 A IL 31000924A IL 310009 A IL310009 A IL 310009A
Authority
IL
Israel
Prior art keywords
acid esters
willi syndrome
cannabidiolic acid
treating prader
prader
Prior art date
Application number
IL310009A
Other languages
English (en)
Hebrew (he)
Inventor
Reshef Swisa
Rotem Sher
Ron Shahrabani
Joseph Tam
Original Assignee
Epm Ip Inc
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd
Reshef Swisa
Rotem Sher
Ron Shahrabani
Joseph Tam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epm Ip Inc, Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd, Reshef Swisa, Rotem Sher, Ron Shahrabani, Joseph Tam filed Critical Epm Ip Inc
Publication of IL310009A publication Critical patent/IL310009A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/658Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/348Cannabaceae
    • A61K36/3482Cannabis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
IL310009A 2021-07-13 2022-07-07 Cannabidiol esters for the treatment of Prader-Willi syndrome IL310009A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163221006P 2021-07-13 2021-07-13
US202163276668P 2021-11-08 2021-11-08
PCT/IL2022/050734 WO2023286047A1 (en) 2021-07-13 2022-07-07 Cannabidiolic acid esters for treating prader-willi syndrome

Publications (1)

Publication Number Publication Date
IL310009A true IL310009A (en) 2024-03-01

Family

ID=84919088

Family Applications (1)

Application Number Title Priority Date Filing Date
IL310009A IL310009A (en) 2021-07-13 2022-07-07 Cannabidiol esters for the treatment of Prader-Willi syndrome

Country Status (7)

Country Link
US (1) US20240316073A1 (https=)
EP (1) EP4370106A4 (https=)
JP (1) JP2024528569A (https=)
AU (1) AU2022312764A1 (https=)
CA (1) CA3224271A1 (https=)
IL (1) IL310009A (https=)
WO (1) WO2023286047A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3062814C (en) * 2017-04-27 2023-11-14 Insys Development Company, Inc. Stable cannabinoid formulations
US12403114B2 (en) * 2019-03-12 2025-09-02 Epm (Ip), Inc. Cannabinoid acid ester compositions and uses thereof
WO2021137224A1 (en) * 2020-01-01 2021-07-08 Epm Group, Inc. Cannabidiolic acid esters for treating muscular dystrophy
CN113087599A (zh) * 2020-01-08 2021-07-09 成都百裕制药股份有限公司 大麻二酚衍生物及其制备方法和在医药上的应用

Also Published As

Publication number Publication date
JP2024528569A (ja) 2024-07-30
AU2022312764A1 (en) 2024-01-18
US20240316073A1 (en) 2024-09-26
WO2023286047A1 (en) 2023-01-19
EP4370106A1 (en) 2024-05-22
EP4370106A4 (en) 2025-05-21
CA3224271A1 (en) 2023-01-19

Similar Documents

Publication Publication Date Title
ZA202207792B (en) Method for the fermentative production of guanidinoacetic acid
IL299713A (en) A method for the fermentation production of guanidinoacetic acid
IL299709A (en) A method for the fermentation production of guanidinoacetic acid
CA204456S (en) Rail controller
ZA202106824B (en) Method for the purification of acrylamido-2-methyl-2-propanesulphonic acid
SG11202101134PA (en) Process for producing methacrylic acid or methacrylic acid esters
EP4215539A4 (en) METHOD FOR PURIFYING SUCRALOSE-6-ETHYL ESTER
IL310009A (en) Cannabidiol esters for the treatment of Prader-Willi syndrome
CA216491S (en) Controller
MA55719A (fr) Procédé de traitement du syndrome de sevrage des opioïdes néonatal
GB202100359D0 (en) Method for producing acetic acid
EP4217336C0 (en) PROCESS FOR THE PRODUCTION OF LEVULINIC ACID
IL270970B1 (en) Production method of 3-arylpropionamide compound and 3-arylpropionic acid ester
SG11202101722RA (en) Catalyst for producing methacrylic acid, method for producing same, and method for producing methacrylic acid and methacrylic acid ester
GB2598586B (en) Controller for ePAS system
EP4026826A4 (en) PROCESS FOR PRODUCING ACETIC ACID
SI3980003T1 (sl) Izopropil ester (((1R,2S,5R)-2-izopropil-5-metil-cikloheksankarbonil)- amino)-ocetne kisline za zdravljenje kroničnega kašlja
EP4053098A4 (en) METHOD FOR PRODUCING A FLUOROACETIC ACID ESTER
GB202002272D0 (en) Controller
GB202317220D0 (en) Esterification method
CA230440S (en) Controller
GB2631809B (en) Desulphurisation process
HK40101782A (en) Dicarboxylic acid esters for inducing an analgesic effect
CA229378S (en) Mount for game controller
EP3257838A4 (en) Method for producing levulinic acid ester